TEST BANK N
Tietz Fundamentals Of
N N
CLINICAL CHEMISTRY AND
N N N
MOLECULAR DIAGNOSTICS N
7th Edition By Carl A. Burtis
N N N N N
TEST BANK N
,TietzNFundamentalsNofNClinicalNChemistryNandNMolecularNDiagnosticsN7thN EditionNTestNBank
TableNofNcontents:
I.NPrinciplesNOfNLaboratoryNMedicine
ChapterN1.NClinicalNChemistry,NMolecularNDiagnostics,NandNLaboratoryNMedicine
ChapterN2.NSelectionNandNAnalyticalNEvaluationNofNMethodsN—NWithNStatisticalNTechniques
ChapterN3.NClinicalNEvaluationNofNMethods
ChapterN4.NEvidence-BasedNLaboratoryNMedicine
ChapterN5.NEstablishmentNandNUseNofNReferenceNValues
ChapterN6.NSpecimenNCollection,NProcessing,NandNOtherNPreanalyticalNVariables
ChapterN7.NQualityNManagement
II.NAnalyticalNTechniquesNAndNInstrumentation
ChapterN8.NPrinciplesNofNBasicNTechniquesNandNLaboratoryNSafety
ChapterN9.NOpticalNTechniques
ChapterN10.NElectrochemistryNandNChemicalNSensors
ChapterN11.NElectrophoresis
ChapterN12.NChromatography
ChapterN13.NMassNSpectrometry
ChapterN14.NEnzymeNandNRateNAnalyses
ChapterN15.NImmunochemicalNTechniques
ChapterN16NAutomation
ChapterN17.NPoint-of-CareNInstrumentation
III.N Analytes
ChapterN18.NAminoNAcids,NPeptides,NandNProteins
ChapterN19.NSerumNEnzymes
ChapterN20.NTumorNMarkersNandNCancerNGenes
ChapterN21.NKidneyNFunctionNTestsN—NCreatinine,NGFR,NUrea,NandNUricNAcid
ChapterN22.NCarbohydrates
ChapterN23.NLipids,NLipoproteins,NApolipoproteins,NandNOtherNCardiacNRiskNFactors
ChapterN24.NElectrolytesNandNBloodNGases
ChapterN25.NHormones
ChapterN26.N CatecholaminesNandNSerotonin
ChapterN27.N Vitamins,NTraceNElements,NNutritionalNAssessment
ChapterN28.NHemoglobin,NIron,NandNBilirubin
ChapterN29.NPorphyrinsNandNPorphyrias
ChapterN30.NTherapeuticNDrugsNandNTheirNManagement
ChapterN31.NClinicalNToxicology
ChapterN32.N ToxicNMetals
IV.N Pathophysiology
ChapterN33.NDiabetes
,ChapterN34.N CardiovascularNDisease
ChapterN35.NKidneyNDisease
ChapterN36.N PhysiologyNandNDisordersNofNWater,NElectrolyte,NandNAcid-BaseNMetabolism
ChapterN37.NNLiverNDisease
ChapterN38.N GastrointestinalNandNPancreaticNDiseases
ChapterN39.N DisordersNofNBoneNandNMineralNMetabolism
ChapterN40.N DisordersNofNtheNPituitaryNGland
ChapterN41.N DisordersNofNtheNAdrenalNCortex
ChapterN42.N ThyroidNDisorders
ChapterN43.N Reproduction-RelatedNDisorders
ChapterN44.NNPregnancyNandNPrenatalNTesting
ChapterN45.N NewbornNScreeningNandN InbornNErrorsNofNMetabolism
ChapterN46.NPharmacogenetics
V.N MolecularNDiagnostics
ChapterN47.NPrinciplesNofNMolecularNBiology
ChapterN48.NNucleicNAcidNTechniquesNandNApplications
ChapterN49.NGenomesNandNNucleicNAcidNAlterations
, TietzNFundamentalsNofNClinicalNChemistryNandNMolecularDiagnostics,N7eNBurtisNTestNBank
ChapterN01:NClinicalNChemistry,NMolecularNDiagnostics,NandNLaboratoryNMedicineTes
tNBank
MULTIPLENCHOICE
1. AnNindividualNworkingNinNaNclinicalNchemistryNlaboratoryNisNmarriedNtoNaNsalesNrepresentativ
eNwhoNworksNforNaNcompanyNthatNsellsNchemistryNlaboratoryNsupplies.NWhenNtheNlaboratoryN
managerNrequestsNaNlistNofNneededNsupplies,NcostNofNsupplies,NandNvendors,NthisNindividualNon
lyNrecommendsNtheNspouse’sNcompanyNasNtheNvendor.NThisNisNconsideredNtoNbeNa(n):
a. accountingNissue.
b. possibleNconflictNofNinterest.
c. maintenanceNofNconfidentialityNissue.
d. problemNwithNresourceNallocation.
ANS:N B
ConcernNhasNbeenNraisedNoverNtheNinterrelationshipsNbetweenNpractitionersNinNtheNmedicalNfie
ldNandNcommercialNsuppliersNofNdrugs,Ndevices,Nequipment,Netc.,NtoNtheNmedicalNprofession.
Similarly,NrelationshipsNhaveNbeenNscrutinizedNbetweenNclinicalNlaboratoriansNandNmanufactur
ersNandNprovidersNofNdiagnosticNequipmentNandNsupplies.NTheseNconcernsNledNtheNNationalNIns
titutesNofNHealthN(NIH)NinN1995NtoNrequireNofficialNinstitutionalNreviewNofNfinancialNdisclosureN
byNresearchersNandNmanagementNofNsituationsNinNwhichNdisclosureNindicatesNpotentialNconflictsN
ofNinterest.
DIF: 1 REF:NNNPageN4-5 OBJ:N 6N|N7
2. ANpatientNvisitsNherNphysicianNstatingNthatNherNprescribedNpainkillerNisNnotNworkingNtoNredu
ceNtheNpainNfollowingNherNrecentNsurgery.NANfriendNofNtheNpatientNclaimsNthatNtheNsameNpain
killerN“workedNwonders”NtoNreduceNherNpainNafterNtheNsameNsurgery.NTheNphysicianNstatesNth
atNtheNdifferenceNinNtheNeffectNofNtheNdrugNmightNbeNcausedNby
,NwhichNisNstudiedNinNpharmacogenetics.
a. epidemiology
b. anNinheritedNdisease
c. aNconflictNofNinterest
d. aNgeneticNvariationNinNdrug-metabolizingNenzymes
ANS:N D
PharmacogeneticsNisNtheNstudyNofNtheNgeneticNvariationNofNdrugNmetabolismNbetwee
nNindividuals.
DIF: 1 REF:NNNPageN3 OBJ:N 1
3. JohnNworksNinNaNmolecularNdiagnosticsNlaboratoryNandNreceivesNaNbloodNsampleNthatNhasNth
eNnameNofNaNcloseNfriendNprintedNonNtheNbar-
codedNlabel.NTheNgeneticNtestNthatNisNorderedNonNtheNfriend’sNsampleNwouldNprovideNdiagnos
ticNinformationNaboutNaNdisorderNthatNhasNaNpoorNprognosis,NandNtheNtestNisNusuallyNperform
edNbyNJohn.NHeNasksNaNfellowNemployeeNtoNanalyzeNtheNsampleNforNhimNandNnotNdivulgeNtheN
results.NThisNethicalNissueNconcerns:
a. confidentialityNofNpatientNgeneticNandNmedicalNinformation.
b. aNconflictNofNinterest.
c. resourceNallocation.
d. diagnosticNaccuracy.
Tietz Fundamentals Of
N N
CLINICAL CHEMISTRY AND
N N N
MOLECULAR DIAGNOSTICS N
7th Edition By Carl A. Burtis
N N N N N
TEST BANK N
,TietzNFundamentalsNofNClinicalNChemistryNandNMolecularNDiagnosticsN7thN EditionNTestNBank
TableNofNcontents:
I.NPrinciplesNOfNLaboratoryNMedicine
ChapterN1.NClinicalNChemistry,NMolecularNDiagnostics,NandNLaboratoryNMedicine
ChapterN2.NSelectionNandNAnalyticalNEvaluationNofNMethodsN—NWithNStatisticalNTechniques
ChapterN3.NClinicalNEvaluationNofNMethods
ChapterN4.NEvidence-BasedNLaboratoryNMedicine
ChapterN5.NEstablishmentNandNUseNofNReferenceNValues
ChapterN6.NSpecimenNCollection,NProcessing,NandNOtherNPreanalyticalNVariables
ChapterN7.NQualityNManagement
II.NAnalyticalNTechniquesNAndNInstrumentation
ChapterN8.NPrinciplesNofNBasicNTechniquesNandNLaboratoryNSafety
ChapterN9.NOpticalNTechniques
ChapterN10.NElectrochemistryNandNChemicalNSensors
ChapterN11.NElectrophoresis
ChapterN12.NChromatography
ChapterN13.NMassNSpectrometry
ChapterN14.NEnzymeNandNRateNAnalyses
ChapterN15.NImmunochemicalNTechniques
ChapterN16NAutomation
ChapterN17.NPoint-of-CareNInstrumentation
III.N Analytes
ChapterN18.NAminoNAcids,NPeptides,NandNProteins
ChapterN19.NSerumNEnzymes
ChapterN20.NTumorNMarkersNandNCancerNGenes
ChapterN21.NKidneyNFunctionNTestsN—NCreatinine,NGFR,NUrea,NandNUricNAcid
ChapterN22.NCarbohydrates
ChapterN23.NLipids,NLipoproteins,NApolipoproteins,NandNOtherNCardiacNRiskNFactors
ChapterN24.NElectrolytesNandNBloodNGases
ChapterN25.NHormones
ChapterN26.N CatecholaminesNandNSerotonin
ChapterN27.N Vitamins,NTraceNElements,NNutritionalNAssessment
ChapterN28.NHemoglobin,NIron,NandNBilirubin
ChapterN29.NPorphyrinsNandNPorphyrias
ChapterN30.NTherapeuticNDrugsNandNTheirNManagement
ChapterN31.NClinicalNToxicology
ChapterN32.N ToxicNMetals
IV.N Pathophysiology
ChapterN33.NDiabetes
,ChapterN34.N CardiovascularNDisease
ChapterN35.NKidneyNDisease
ChapterN36.N PhysiologyNandNDisordersNofNWater,NElectrolyte,NandNAcid-BaseNMetabolism
ChapterN37.NNLiverNDisease
ChapterN38.N GastrointestinalNandNPancreaticNDiseases
ChapterN39.N DisordersNofNBoneNandNMineralNMetabolism
ChapterN40.N DisordersNofNtheNPituitaryNGland
ChapterN41.N DisordersNofNtheNAdrenalNCortex
ChapterN42.N ThyroidNDisorders
ChapterN43.N Reproduction-RelatedNDisorders
ChapterN44.NNPregnancyNandNPrenatalNTesting
ChapterN45.N NewbornNScreeningNandN InbornNErrorsNofNMetabolism
ChapterN46.NPharmacogenetics
V.N MolecularNDiagnostics
ChapterN47.NPrinciplesNofNMolecularNBiology
ChapterN48.NNucleicNAcidNTechniquesNandNApplications
ChapterN49.NGenomesNandNNucleicNAcidNAlterations
, TietzNFundamentalsNofNClinicalNChemistryNandNMolecularDiagnostics,N7eNBurtisNTestNBank
ChapterN01:NClinicalNChemistry,NMolecularNDiagnostics,NandNLaboratoryNMedicineTes
tNBank
MULTIPLENCHOICE
1. AnNindividualNworkingNinNaNclinicalNchemistryNlaboratoryNisNmarriedNtoNaNsalesNrepresentativ
eNwhoNworksNforNaNcompanyNthatNsellsNchemistryNlaboratoryNsupplies.NWhenNtheNlaboratoryN
managerNrequestsNaNlistNofNneededNsupplies,NcostNofNsupplies,NandNvendors,NthisNindividualNon
lyNrecommendsNtheNspouse’sNcompanyNasNtheNvendor.NThisNisNconsideredNtoNbeNa(n):
a. accountingNissue.
b. possibleNconflictNofNinterest.
c. maintenanceNofNconfidentialityNissue.
d. problemNwithNresourceNallocation.
ANS:N B
ConcernNhasNbeenNraisedNoverNtheNinterrelationshipsNbetweenNpractitionersNinNtheNmedicalNfie
ldNandNcommercialNsuppliersNofNdrugs,Ndevices,Nequipment,Netc.,NtoNtheNmedicalNprofession.
Similarly,NrelationshipsNhaveNbeenNscrutinizedNbetweenNclinicalNlaboratoriansNandNmanufactur
ersNandNprovidersNofNdiagnosticNequipmentNandNsupplies.NTheseNconcernsNledNtheNNationalNIns
titutesNofNHealthN(NIH)NinN1995NtoNrequireNofficialNinstitutionalNreviewNofNfinancialNdisclosureN
byNresearchersNandNmanagementNofNsituationsNinNwhichNdisclosureNindicatesNpotentialNconflictsN
ofNinterest.
DIF: 1 REF:NNNPageN4-5 OBJ:N 6N|N7
2. ANpatientNvisitsNherNphysicianNstatingNthatNherNprescribedNpainkillerNisNnotNworkingNtoNredu
ceNtheNpainNfollowingNherNrecentNsurgery.NANfriendNofNtheNpatientNclaimsNthatNtheNsameNpain
killerN“workedNwonders”NtoNreduceNherNpainNafterNtheNsameNsurgery.NTheNphysicianNstatesNth
atNtheNdifferenceNinNtheNeffectNofNtheNdrugNmightNbeNcausedNby
,NwhichNisNstudiedNinNpharmacogenetics.
a. epidemiology
b. anNinheritedNdisease
c. aNconflictNofNinterest
d. aNgeneticNvariationNinNdrug-metabolizingNenzymes
ANS:N D
PharmacogeneticsNisNtheNstudyNofNtheNgeneticNvariationNofNdrugNmetabolismNbetwee
nNindividuals.
DIF: 1 REF:NNNPageN3 OBJ:N 1
3. JohnNworksNinNaNmolecularNdiagnosticsNlaboratoryNandNreceivesNaNbloodNsampleNthatNhasNth
eNnameNofNaNcloseNfriendNprintedNonNtheNbar-
codedNlabel.NTheNgeneticNtestNthatNisNorderedNonNtheNfriend’sNsampleNwouldNprovideNdiagnos
ticNinformationNaboutNaNdisorderNthatNhasNaNpoorNprognosis,NandNtheNtestNisNusuallyNperform
edNbyNJohn.NHeNasksNaNfellowNemployeeNtoNanalyzeNtheNsampleNforNhimNandNnotNdivulgeNtheN
results.NThisNethicalNissueNconcerns:
a. confidentialityNofNpatientNgeneticNandNmedicalNinformation.
b. aNconflictNofNinterest.
c. resourceNallocation.
d. diagnosticNaccuracy.
